Amgen (AMGN) Enterprise Value (2009 - 2026)

Amgen has reported Enterprise Value for 18 years, with the latest figure at $181.8 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 27.77% year-over-year to $181.8 billion in Q2 2026; TTM through Jun 2026 was $181.8 billion, a 27.77% increase from a year earlier, with the FY2025 full-year figure at $167.2 billion, up 30.68% from the prior year.
• Enterprise Value was $181.8 billion for Q2 2026 at Amgen, up from $177.9 billion in the prior quarter.
• The five-year high for Enterprise Value was $181.8 billion in Q2 2026, with the low at $84.5 billion in Q2 2023.
• Average Enterprise Value over 5 years is $138.0 billion, with a median of $142.4 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value tumbled 31.27% in 2023, then surged 87.61% in 2024.
• Over 5 years, Enterprise Value stood at $130.9 billion in 2022, then rose by 9.41% to $143.3 billion in 2023, then slipped by 10.68% to $128.0 billion in 2024, then soared by 30.68% to $167.2 billion in 2025, then increased by 8.7% to $181.8 billion in 2026.
• The last three Enterprise Value figures came in at $181.8 billion (Q2 2026), $177.9 billion (Q1 2026), and $167.2 billion (Q4 2025), per Business Quant data.